Trials / Completed
CompletedNCT01755078
Long Term Evaluation of Sevelamer HCl vs. Calcium-based Phosphate Binder in the Treatment of Hyperphosphatemia in Hemodialysis Patients
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 166 (actual)
- Sponsor
- Chugai Pharma Taiwan · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The study is designed to compare sevelamer vs. calcium-based phosphate binder in hemodialysis patients to achieve full-scale of medical care, including reduction of atherosclerotic risk factors, reduction of vascular access reconstruction rate, and pharmacoeconomic analysis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Sevelamer HCl | Non-metal phosphate binder |
| DRUG | Calcium-based phosphate binder |
Timeline
- Start date
- 2007-06-01
- Primary completion
- 2009-06-01
- Completion
- 2009-06-01
- First posted
- 2012-12-21
- Last updated
- 2014-08-05
Source: ClinicalTrials.gov record NCT01755078. Inclusion in this directory is not an endorsement.